These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19001688)

  • 1. Experience of conducting a phase I safety & acceptability clinical trial of a candidate vaginal microbicide & lessons learned.
    Dutta S; Joglekar N; Joshi S; Steven JR
    Indian J Med Res; 2008 Aug; 128(2):212-3. PubMed ID: 19001688
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
    Abdool Karim SS
    Future Microbiol; 2010 Apr; 5(4):527-9. PubMed ID: 20353292
    [No Abstract]   [Full Text] [Related]  

  • 3. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy.
    Saethre EJ; Stadler J
    Anthropol Med; 2010 Apr; 17(1):99-111. PubMed ID: 20419520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention.
    Nunn A; McCormack S; Crook AM; Pool R; Rutterford C; Hayes R
    Trials; 2009 Oct; 10():99. PubMed ID: 19860888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparing for efficacy trials of vaginal microbicides in Indian women.
    Joshi S; Solomon S; Mayer K; Mehendale S
    Indian J Med Res; 2005 Apr; 121(4):502-9. PubMed ID: 15817959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergent HIV technology: urban Tanzanian women's narratives of medical research, microbicides and sexuality.
    Lees S
    Cult Health Sex; 2015; 17(4):412-27. PubMed ID: 25317758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of a broad-spectrum antimicrobial preparation in vaginits.
    Robinson SC
    Can Med Assoc J; 1969 Jan; 100(4):224-5. PubMed ID: 5763433
    [No Abstract]   [Full Text] [Related]  

  • 10. [The vaginal tampon as a carrier of drugs for local treatment of the vagina].
    Beller FK; Dame W
    Med Welt; 1979 May; 30(18):709-10. PubMed ID: 440065
    [No Abstract]   [Full Text] [Related]  

  • 11. Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned.
    Joshi S; Dutta S; Bell B; Profy A; Kuruc J; Fang G; Cianciola M; Maslankowski L; Soto-Torres L; Panchanadikar A; Mehendale S; Reynolds SJ
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):294-6. PubMed ID: 16545017
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbicides and HIV prevention: lessons from the past, looking to the future.
    Morris GC; Lacey CJ
    Curr Opin Infect Dis; 2010 Feb; 23(1):57-63. PubMed ID: 19918175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study.
    Petersen EE; Weissenbacher ER; Hengst P; Spitzbart H; Weise W; Wolff F; Dreher E; Ernst U; Della Casa V; Pohlig G; Graf F; Kaiser RR
    Arzneimittelforschung; 2002; 52(9):706-15. PubMed ID: 12404887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbicide offers no protection against HIV infection.
    Roehr B
    BMJ; 2009 Dec; 339():b5538. PubMed ID: 20022912
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model.
    Spencer SE; Valentin-Bon IE; Whaley K; Jerse AE
    J Infect Dis; 2004 Feb; 189(3):410-9. PubMed ID: 14745698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS; Joshi SN; Deshpande SS; Parkhe AN; Katti UR; Mehendale SM
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa.
    Gafos M; Mzimela M; Ndlovu H; Mhlongo N; Hoogland Y; Mutemwa R
    PLoS One; 2011 Jan; 6(1):e14577. PubMed ID: 21344002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S; Joglekar N; Ghate M; Unni J; Risbud A; Bentley M; Shepherd M; Bollinger R; Mehendale S
    Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
    Woodsong C; Alleman P
    AIDS Educ Prev; 2008 Apr; 20(2):171-87. PubMed ID: 18433322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study.
    Joglekar NS; Joshi SN; Navlakha SN; Katti UR; Mehendale SM
    Indian J Med Res; 2006 Apr; 123(4):547-52. PubMed ID: 16783046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.